CM
Caption Management Portfolio holdings
AUM
$1.09B
This Quarter Return
+2.11%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$1.09B
AUM Growth
+$1.09B
(-50%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-110.09%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
1,115
New
230
Increased
115
Reduced
111
Closed
247
Top Buys
| 1 |
Insmed
INSM
|
$21.2M |
| 2 |
Skechers
SKX
|
$20.1M |
| 3 |
Gilead Sciences
GILD
|
$16.5M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$16.4M |
| 5 |
Kellanova
K
|
$14.9M |
Top Sells
| 1 |
Microsoft
MSFT
|
$394M |
| 2 |
Amazon
AMZN
|
$314M |
| 3 |
NVIDIA
NVDA
|
$255M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$130M |
| 5 |
Cisco
CSCO
|
$61.7M |
Sector Composition
| 1 | Healthcare | 25.54% |
| 2 | Consumer Discretionary | 20.68% |
| 3 | Technology | 13.45% |
| 4 | Financials | 8.7% |
| 5 | Communication Services | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tesla
TSLA
$1.08T
| $95.3M | 1.05% | 300,000 +4,000 | +1% | +$1.27M |
|
|
2
Alphabet (Google) Class C
GOOG
$2.58T
| $40.2M | 0.44% | 226,397 -307,028 | -58% | -$54.5M |
|
3
Soleno Therapeutics
SLNO
$3.6B
| $22.1M | 0.24% | 263,287 -31,713 | -11% | -$2.66M |
|
|
4
Insmed
INSM
$28.8B
| $21.2M | 0.24% | +210,928 | New | +$21.2M |
|
|
5
Skechers
SKX
$9.48B
| $20.1M | 0.22% | +317,932 | New | +$20.1M |
|
|
6
Gilead Sciences
GILD
$140B
| $16.5M | 0.18% | +148,600 | New | +$16.5M |
|
|
7
Regeneron Pharmaceuticals
REGN
$61.5B
| $16.4M | 0.18% | +31,200 | New | +$16.4M |
|
|
8
Kellanova
K
$27.6B
| $15M | 0.17% | 188,281 +187,145 | +16,474% | +$14.9M |
|
9
iShares MSCI India ETF
INDA
$9.17B
| $14.2M | 0.16% | +255,280 | New | +$14.2M |
|
10
Galicia Financial Group
GGAL
$6.31B
| $13.9M | 0.15% | 275,708 +28,206 | +11% | +$1.42M |
|
11
Mastercard
MA
$538B
| $13.3M | 0.15% | +23,700 | New | +$13.3M |
|
12
Cidara Therapeutics
CDTX
$1.66B
| $13.1M | 0.14% | +268,000 | New | +$13.1M |
|
13
Starbucks
SBUX
$100B
| $12M | 0.13% | +131,000 | New | +$12M |
|
14
Visa
V
$683B
| $11.4M | 0.13% | 32,000 | – | – |
|
15
ARK Innovation ETF
ARKK
$7.45B
| $10.9M | 0.12% | 154,700 -7,400 | -5% | -$520K |
|
16
Janux Therapeutics
JANX
$1.37B
| $10.6M | 0.12% | 457,012 +412,569 | +928% | +$9.53M |
|
17
Boot Barn
BOOT
$5.43B
| $10.3M | 0.11% | 68,000 +45,500 | +202% | +$6.92M |
|
18
Arvinas
ARVN
$568M
| $9.88M | 0.11% | 1,343,029 +1,279,329 | +2,008% | +$9.42M |
|
|
CBL
19
CBL Properties
CBL
$985M
| $8.81M | 0.1% | 347,059 -97,551 | -22% | -$2.48M |
|
20
Vistra
VST
$64.1B
| $8.72M | 0.1% | 45,000 +34,300 | +321% | +$6.65M |
|
21
Ultragenyx Pharmaceutical
RARE
$2.89B
| $8.64M | 0.1% | 237,500 +58,672 | +33% | +$2.13M |
|
22
Henry Schein
HSIC
$8.44B
| $8.62M | 0.1% | 118,000 +111,138 | +1,620% | +$8.12M |
|
23
Nice
NICE
$8.73B
| $8.52M | 0.09% | +50,416 | New | +$8.52M |
|
24
Core Scientific, Inc. Tranche 1 Warrants
CORZW
$812M
| $8.15M | 0.09% | 751,544 +251,544 | +50% | +$2.73M |
|
25
Natera
NTRA
$23.1B
| $7.6M | 0.08% | +45,000 | New | +$7.6M |
|